(Q53140520)

11 May 2018

title

Divergent results induced by different types of septic shock in transglutaminase 2 knockout mice. (English)

1 reference

11 May 2018

0 references

1 reference

Hyun Yoo

1

1 reference

11 May 2018

Eu-Ree Ahn

2

1 reference

11 May 2018

Se-Jin Kim

3

1 reference

11 May 2018

Seon-Hyeong Lee

4

1 reference

11 May 2018

Seung Hyun Oh

5

1 reference

11 May 2018

Soo-Youl Kim

6

1 reference

11 May 2018

publication date

10 October 2012

1 reference

11 May 2018

published in

Amino Acids

1 reference

11 May 2018

volume

44

1 reference

11 May 2018

issue

1

1 reference

11 May 2018

page(s)

189-197

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1007/s00726-012-1412-x

exact match

0 references

cites work

Transglutaminase 2 is involved in autophagosome maturation

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1412-X

Gene disruption of tissue transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1412-X

TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1412-X

Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1412-X

Transglutaminase 2 gene ablation protects against renal ischemic injury by blocking constant NF-κB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1412-X

Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1412-X

Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1412-X

Targeted inactivation of Gh/tissue transglutaminase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1412-X

Transglutaminase type II plays a protective role in hepatic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1412-X

Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1412-X

Transglutaminase 2 mediates polymer formation of I-kappaBalpha through C-terminal glutamine cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1412-X

TNF-alpha mediated NF-kappaB activation is constantly extended by transglutaminase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1412-X

Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1412-X

Inflammatory pathways in liver homeostasis and liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1412-X

Classically and alternatively activated bone marrow derived macrophages differ in cytoskeletal functions and migration towards specific CNS cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1412-X

Tissue transglutaminase serves as an inhibitor of apoptosis by cross-linking caspase 3 in thapsigargin-treated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1412-X

10.1007/S00726-012-1412-X

21 January 2018

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018